By Nathan Hale ( September 30, 2021, 9:54 PM EDT) -- Florida-based Catalyst Pharmaceuticals Inc. won a decision on Thursday in the Eleventh Circuit, which found that the U.S. Food and Drug Administration unlawfully infringed on an exclusivity period it awarded the company for a drug that treats a rare autoimmune disease when it approved a lower-cost version....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.